Financial statements Bioxon Laboratorium

Balance sheet of Bioxon Laboratorium

Company age:
Age:
11 y. 9 m. 15 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of BIOXON LABORATORIUM

Year
2019
2020
2021
2022
2023
Total assets 155 498,43 376 144,78 851 535,07 1 282 025,83 2 421 058,71
A. Fixed assets 0,00 0,00 0,00 172 960,28 683 336,34
B. Current assets 155 498,43 376 144,78 851 535,07 1 109 065,55 1 737 722,37
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00
Total liabilities 155 498,43 376 144,78 851 535,07 1 282 025,83 2 421 058,71
A. Equity 65 043,11 288 692,57 590 170,75 881 798,87 1 235 522,43
B. Liabilities and provisions for liabilities 90 455,32 87 452,21 261 364,32 400 226,96 1 185 536,28
I. Long-term liabilities 0,00 0,00 0,00 0,00 195 917,25
II. Short-term liabilities 90 455,32 87 452,21 261 364,32 362 690,96 989 619,03
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.